BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth
July 02 2024 - 7:19AM
InvestorsHub NewsWire
BNCM and DELEX Healthcare
Group Announce Strategic Merger to Drive Expansion and
Growth
July 2, 2024 -- InvestorsHub
NewsWire -- Bounce Mobile Systems Inc. (BNCM)
and DELEX Healthcare Group Inc. (DELEX) are excited to announce
their Strategic Merger to further drive their expansion and growth
plans.
Delex Healthcare Group, Inc.
(DELEX), also known as DLX Holdings Inc., holds a 60% stake in
Delex Pharma International, Inc. in the Philippines. Delex Pharma
is an ISO 9001:2015-certified pharmaceutical and medical device
company, ranked as the 3rd largest among National Companies (NC) in
hospital channels according to IQVIA.
BNCM is an Asset Management Company
that secures its assets by investing in companies with experienced
management, strong growth, track records and qualify for listing on
the OTC and or NASDAQ Market within the next 2 to 3 years. The
growth of these companies will directly provide more employment
opportunities to the communities, improve the country's economy,
and bring greater social change to humanity.
Driven by a shared objective, DELEX
and BNCM formed a strategic alliance to elevate the pharmaceutical
industry in the Philippines to align with its status as one of the
most attractive pharmaceutical markets in the Asia-Pacific region.
The proposed merger further supports the aim of DELEX to meet the
gaps in critical care by providing alternative drugs for Intensive
Care Unit (ICU) patients.
J. de Ruyter Oroceo, CEO and
Chairman of the Board of DELEX, stated, "The proposed merger
represents a significant opportunity for DELEX to accelerate and
enhance its growth plans both domestically and regionally. This
merger will enable DELEX to expand its Pharma Franchise by
strengthening distribution capabilities in both retail and
wholesale. Additionally, we will bolster product and market
development, as well as backward and forward integration
initiatives, through manufacturing and the expansion of Delex
Pharmacy stores nationwide. These efforts are aimed at increasing
revenues, profitability, and market value for our
shareholders."
"The merger will enhance the market
value of BNCM and enable us to focus on asset management,
compliance, and other acquisition or expansion plans in partnership
with DELEX.” Paul Hatadi, President of BNCM, also noted with
enthusiasm.
The Impact of DELEX on the
Philippine Pharmaceutical Industry
Setting its sights on the Philippine Pharmaceutical Industry which
had total sales amounting to 236 billion (approx. US$4.20 billion)
as of September 2022, DELEX, one of the leading market providers of
Intensive Care Unit (ICU) products, currently distributes to over
600 hospitals and healthcare centers with a total of 23 pharma
product lines covering critical care, anesthesia, oncology and
anti-infectives. Two of the products under DELEX, Norepin and
Ifimol, have a market penetration of 90% in hospitals nationwide.
It also owns five (5) brands with approved IPO-listed trademarks,
and five (5) brands for distribution to the global markets. The
distribution includes 4 product groups of medical devices mainly
for intensive care settings in the ICU, and emergency and operating
rooms. These include Philips Ultrasound from the Netherlands, CADD
Solis from ICU Medical Inc. (USA), CAIR Devices from France, and
Glidescope from Verathon USA.
A Promising
Future
This merger between DELEX and BNCM serves as a pivotal milestone
for both parties as DELEX continues its expansion to develop more
product ranges, expand its global distribution channels, and
consistently become a market leader for delivering quality and
cost-effective medicines and medical devices to its hospital
partners. With the Philippine government’s continued support to
further the growth and competitiveness of the industry, and powered
by the combined expertise of both companies, the merger is expected
to reach new heights in the years to come. This merger also
promises significant benefits to current and future investors and
other shareholders, as it enhances the company's financial
stability and growth prospects, thereby generating greater returns
and value for their investments.
About Bounce Mobile Systems, Inc. (OTC:
BNCM)
BNCM is an Asset Management Company that secures its assets by
investing in companies with strong growth potentials, robust
revenues, significant profits, proven track records, and promising
business models with highly experienced management teams that will
exceptionally qualify for quotation and or listing on the OTC and
or NASDAQ Market within the next 2 to 3 years. The growth of these
companies will directly provide more employment opportunities to
the communities, improve the country's economy, and bring greater
social change to humanity.
About Delex Healthcare Group, Inc. (DELEX)
DELEX is a Delaware-registered company, and a holding company of
DLX Holdings, Inc. (DLX). DLX is a Philippine-based parent company
that holds a 60% controlling interest in Delex Pharma
International, Inc. while also holding a 46% controlling interest
in JMN Brother's Pharma Limited, Inc. DLX and its subsidiaries are
involved in the development and distribution of pharmaceutical and
healthcare products in the Philippines.
Bounce Mobile Systems (PK) (USOTC:BNCM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bounce Mobile Systems (PK) (USOTC:BNCM)
Historical Stock Chart
From Jul 2023 to Jul 2024
